Summary of clinical results
DUCRAY
Tolerance and efficacy of KERACNYL serum in monotherapy
Tolerance and efficacy of KERACNYL serum in monotherapy in adult women with mild to moderate acne, crow's feet wrinkles and fine lines, under dermatological control
Population
60 adult women aged 20-50:
- 30 subjects with mild to moderate facial acne, with at least one Post-Inflammatory Erythema (PIE) and/or Post-Inflammatory Hyperpigmentation (PIH)
- 30 subjects with wrinkles and fine lines in the crow's feet area (score ≥ 2 and < 4 according to the Bazin photographic atlas)
Application of KERACNYL serum
Application twice a day (morning/evening) to the entire face for 8 weeks
Evaluation criteria
- Clinical scoring of efficacy on acne lesions: Lucky Method acne lesion count
- Evaluation of efficacy on residual marks due to inflammation and hyperpigmentation (PIE and PIH)
- Evaluation of anti-aging efficacy by analysis of the crow's feet prints (maximum depth of wrinkles / fine lines)
- Skin tolerance
Results
- From 7 days, significant decrease in the number of total inflammatory lesions, which continues to reach –62% after 8 weeks
- At 1 month, significant decrease in the surface area of post-inflammatory hyperpigmentation lesions of -42% (p<0.05)
- A 1 month, significant decrease in the maximum depth of wrinkles of –20% (p<0.05)
- Good skin tolerance
Conclusion
- Efficacy on Acne in adult women from 7 days
- Anti-wrinkle and anti-fine line action
- Good tolerance
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.